AI-09

· Eirion Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AI-09, covering 2025-08-27 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate AI-09 In Participants With Glabellar Lines [Phase 2]